Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Retinal Vein Occlusion with Macular Oedema”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04290195
What this trial is testing

Use of Ziv Aflibercept in Different Retinal Diseases

Who this might be right for
Central Retinal Vein Occlusion With Macular Edema
Amin El Sayed Nawar 55
Testing effectiveness (Phase 2)Study completedNCT02387788
What this trial is testing

Open Label Study to Assess the Efficacy and Safety of AKB-9778 in Subjects With Macular Edema Due to RVO

Who this might be right for
Retinal Vein Occlusion
Aerpio Therapeutics 16
Not applicableStudy completedNCT01571557
What this trial is testing

A Safety and Efficacy Study to Assess OZURDEX® in Patients With Macular Oedema Secondary to Retinal Vein Occlusion (RVO)

Who this might be right for
Macular EdemaRetinal Vein Occlusion
Allergan 573
Testing effectiveness (Phase 2)Study completedNCT02006147
What this trial is testing

Phase 1 Open-label Study to Evaluate Efficacy and Tolerability of TLC399 in Patients With Macular Edema Due to RVO

Who this might be right for
Central Retinal Vein Occlusion With Macular EdemaBranch Retinal Vein Occlusion With Macular Edema
Taiwan Liposome Company 14
Early research (Phase 1)Study completedNCT04635800
What this trial is testing

Evaluate the Safety, Tolerability and Pharmacokinetics of IVT MHU650 in Macular Edema Patients

Who this might be right for
Macular EdemaDiabetic Macular EdemaNeovascular Age-related Macular Degeneration+1 more
Novartis Pharmaceuticals 21
Testing effectiveness (Phase 2)Study completedNCT03093701
What this trial is testing

TLC399 (ProDex) in Subjects With Macular Edema Due to Retinal Vein Occlusion (RVO)

Who this might be right for
Retinal Vein OcclusionMacula Edema
Taiwan Liposome Company 31
Early research (Phase 1)Study completedNCT02867735
What this trial is testing

Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Activity of Intravitreal LKA651 in Patients With Macular Edema

Who this might be right for
Macular EdemaDiabetic Macular EdemaNeovascular Age-related Macular Degeneration+1 more
Novartis Pharmaceuticals 28
Early research (Phase 1)Ended earlyNCT00969293
What this trial is testing

Study to Assess the Safety and Tolerability of a Single Administration of FOV2302 (Ecallantide) in Patients With Macular Edema Associated With Central Retinal Vein Occlusion

Who this might be right for
Macular EdemaCentral Retinal Vein Occlusion
Fovea Pharmaceuticals SA 11
Large-scale testing (Phase 3)Study completedNCT02698566
What this trial is testing

A Study in Patients With Neovascular Age Related Macular Degeneration or Macular Edema Secondary To Retinal Vein Occlusion to Evaluate Usability of the Ranibizumab (Lucentis®) Prefilled Syringe (PFS)

Who this might be right for
Macular Edema
Genentech, Inc. 35
Post-approval studies (Phase 4)Enrolling By InvitationNCT07456826
What this trial is testing

Study Evaluating the Efficacy and Safety of Chloroprocaine HCl Ophthalmic Gel 3% vs Proparacaine Ophthalmic Solution 0.5% Plus Subconjunctival Lidocaine in Patients Undergoing Intravitreal Injections

Who this might be right for
Diabetic Macular Edema (DME)Age-Related Macular Degeneration (AMD)Retinal Vein Occlusion+1 more
Harrow Inc 236
Not applicableStudy completedNCT05791695
What this trial is testing

The Incidence of Intraocular Inflammation and Suspected Endophthalmitis Among Patients Treated With Aflibercept, Vial and Pre-filled Syringe, 2014-2022

Who this might be right for
Intraocular InflammationSuspected Endophthalmitis
Regeneron Pharmaceuticals 155,413
Large-scale testing (Phase 3)Study completedNCT04740931
What this trial is testing

Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Central Retinal or Hemiretinal Vein Occlusion

Who this might be right for
Macular EdemaCentral Retinal Vein OcclusionHemiretinal Vein Occlusion
Hoffmann-La Roche 729
Early research (Phase 1)Ended earlyNCT03790852
What this trial is testing

Exploratory Study to Investigate the Bioactivity, Ocular and Systemic Safety, Tolerability, and Pharmacokinetics Following Single and Multiple Intravitreal Administrations of KSI-301 in Subjects With wAMD, DME and RVO

Who this might be right for
Wet Age-related Macular DegenerationRetinal Vein OcclusionDiabetic Macular Edema
Kodiak Sciences Inc 121
Large-scale testing (Phase 3)Study completedNCT01976338
What this trial is testing

Ranibizumab Intravitreal Injections Versus Sham Control in Patients With Branch Retinal Vein Occlusion (BRVO)

Who this might be right for
Macular Edema Secondary to Branch Retinal Vein Occlusion
Novartis Pharmaceuticals 283
Testing effectiveness (Phase 2)UnknownNCT01123564
What this trial is testing

Efficacy and Safety of Lucentis for Clinically Significant Macular Edema Secondary to Central Retinal Vein Occlusion

Who this might be right for
Retinal Vein OcclusionMacular Edema
University of Pecs 40
Not applicableStudy completedNCT04847895
What this trial is testing

Observation of Treatment Patterns With Lucentis® in Real-life Conditions in All Approved Indications

Who this might be right for
Neovascular (Wet) Age-related Macular Degeneration
Novartis Pharmaceuticals 5,500
Early research (Phase 1)Study completedNCT01028248
What this trial is testing

Lucentis for Macular Edema Associated With Central Retinal Vein Occlusion

Who this might be right for
Central Retinal Vein Occlusion
California Retina Consultants 20
Post-approval studies (Phase 4)Study completedNCT01870427
What this trial is testing

NEWTON: Aflibercept Injection for Previously Treated Macular Edema Associated With Central Retinal Vein Occlusions

Who this might be right for
Macular Edema With Central Retinal Vein Occlusions
Northern California Retina Vitreous Associates 20
Testing effectiveness (Phase 2)Study completedNCT02571972
What this trial is testing

Dorzolamide-timolol Drops With Injections to Treat AMD, RVO or DME.

Who this might be right for
Wet Macular DegenerationAge-related Macular DegenerationDiabetic Macular Edema+1 more
Wills Eye 14
Post-approval studies (Phase 4)Study completedNCT01767545
What this trial is testing

Dexamethasone-implant for the Treatment of RVO

Who this might be right for
Macular Edema Caused by Retinal Vein Occlusion
Ludwig-Maximilians - University of Munich 64
Next Page